Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide.

Bhattacharya, Udayan; Kamran, Mohammad; Manai, Maroua; Cristofanilli, Massimo; Ince, Tan A

Bhattacharya, Udayan; Kamran, Mohammad; Manai, Maroua; Cristofanilli, Massimo; Ince, Tan A.

Afiliación

Bhattacharya U; Weill Cornell Medicine, Department of Pathology and Laboratory Medicine, New York, NY 10065, USA.
Kamran M; Weill Cornell Medicine, Department of Pathology and Laboratory Medicine, New York, NY 10065, USA.
Manai M; Weill Cornell Medicine, Division of Hematology-Oncology, New York, NY 10065, USA.
Cristofanilli M; Weill Cornell Medicine, Division of Hematology-Oncology, New York, NY 10065, USA.
Ince TA; Weill Cornell Medicine, Department of Pathology and Laboratory Medicine, New York, NY 10065, USA.

Cancers (Basel) ; 15(2)2023 Jan 04.

Article en En | MEDLINE | ID: mdl-36672285

Palabras clave

breast cancer; cell-of-origin; drug repurposing; heat shock protein; histone deacetylase; niclosamide

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google